Molecular pathways triggering glioma cell invasion

Bodour Salhia, Nhan Tran, Marc Symons, Jeffrey A. Winkles, James T. Rutka, Michael E. Berens

Research output: Contribution to journalReview article

55 Citations (Scopus)

Abstract

The efficacy of treating malignant gliomas with adjuvant therapies remains largely unsuccessful due to the inability to effectively target invading cells. Although our understanding of glioma oncogenesis has steadily improved, the molecular mechanisms that mediate glioma invasion are still poorly understood. It is clear that genetic alterations in malignant gliomas affect cell proliferation and cell cycle control, which are the targets of most chemotherapeutic agents. However, effective therapy against cell invasion has been less successful. Future treatment protocols must incorporate pharmacotherapeutic strategies that target resistant infiltrative glioma cells as well as proliferating ones. Thus, delineating the point of convergence of signaling pathways, which mediate glioma invasion, proliferation and apoptosis, may identify novel targets that can serve as possible points of therapeutic intervention. The optimization of novel strategies will require reliable preclinical testing using an in vivo animal model of brain invasion. Current applications of existing animal models are not currently optimized or characterized for use in glioma invasion research. As such, the development of a bona fide brain invasion model in vivo must be established. Progress in understanding molecular mechanisms driving glioma invasion will be critical to the success of managing and improving the outcome of patients with this grave disease.

Original languageEnglish (US)
Pages (from-to)613-626
Number of pages14
JournalExpert Review of Molecular Diagnostics
Volume6
Issue number4
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Glioma
Animal Models
Graves Disease
Brain
Clinical Protocols
Cell- and Tissue-Based Therapy
Cell Cycle Checkpoints
Carcinogenesis
Cell Proliferation
Apoptosis
Therapeutics
Research

Keywords

  • Animal model
  • FAK
  • Fn14
  • Glioma
  • Invasion
  • Migration
  • NF-κB
  • Pyk2
  • Rac1
  • RhoA

ASJC Scopus subject areas

  • Genetics

Cite this

Salhia, B., Tran, N., Symons, M., Winkles, J. A., Rutka, J. T., & Berens, M. E. (2006). Molecular pathways triggering glioma cell invasion. Expert Review of Molecular Diagnostics, 6(4), 613-626. https://doi.org/10.1586/14737159.6.4.613

Molecular pathways triggering glioma cell invasion. / Salhia, Bodour; Tran, Nhan; Symons, Marc; Winkles, Jeffrey A.; Rutka, James T.; Berens, Michael E.

In: Expert Review of Molecular Diagnostics, Vol. 6, No. 4, 2006, p. 613-626.

Research output: Contribution to journalReview article

Salhia, B, Tran, N, Symons, M, Winkles, JA, Rutka, JT & Berens, ME 2006, 'Molecular pathways triggering glioma cell invasion', Expert Review of Molecular Diagnostics, vol. 6, no. 4, pp. 613-626. https://doi.org/10.1586/14737159.6.4.613
Salhia, Bodour ; Tran, Nhan ; Symons, Marc ; Winkles, Jeffrey A. ; Rutka, James T. ; Berens, Michael E. / Molecular pathways triggering glioma cell invasion. In: Expert Review of Molecular Diagnostics. 2006 ; Vol. 6, No. 4. pp. 613-626.
@article{7ffa3550f16b41ff93c7e08a4bd8e4a8,
title = "Molecular pathways triggering glioma cell invasion",
abstract = "The efficacy of treating malignant gliomas with adjuvant therapies remains largely unsuccessful due to the inability to effectively target invading cells. Although our understanding of glioma oncogenesis has steadily improved, the molecular mechanisms that mediate glioma invasion are still poorly understood. It is clear that genetic alterations in malignant gliomas affect cell proliferation and cell cycle control, which are the targets of most chemotherapeutic agents. However, effective therapy against cell invasion has been less successful. Future treatment protocols must incorporate pharmacotherapeutic strategies that target resistant infiltrative glioma cells as well as proliferating ones. Thus, delineating the point of convergence of signaling pathways, which mediate glioma invasion, proliferation and apoptosis, may identify novel targets that can serve as possible points of therapeutic intervention. The optimization of novel strategies will require reliable preclinical testing using an in vivo animal model of brain invasion. Current applications of existing animal models are not currently optimized or characterized for use in glioma invasion research. As such, the development of a bona fide brain invasion model in vivo must be established. Progress in understanding molecular mechanisms driving glioma invasion will be critical to the success of managing and improving the outcome of patients with this grave disease.",
keywords = "Animal model, FAK, Fn14, Glioma, Invasion, Migration, NF-κB, Pyk2, Rac1, RhoA",
author = "Bodour Salhia and Nhan Tran and Marc Symons and Winkles, {Jeffrey A.} and Rutka, {James T.} and Berens, {Michael E.}",
year = "2006",
doi = "10.1586/14737159.6.4.613",
language = "English (US)",
volume = "6",
pages = "613--626",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "4",

}

TY - JOUR

T1 - Molecular pathways triggering glioma cell invasion

AU - Salhia, Bodour

AU - Tran, Nhan

AU - Symons, Marc

AU - Winkles, Jeffrey A.

AU - Rutka, James T.

AU - Berens, Michael E.

PY - 2006

Y1 - 2006

N2 - The efficacy of treating malignant gliomas with adjuvant therapies remains largely unsuccessful due to the inability to effectively target invading cells. Although our understanding of glioma oncogenesis has steadily improved, the molecular mechanisms that mediate glioma invasion are still poorly understood. It is clear that genetic alterations in malignant gliomas affect cell proliferation and cell cycle control, which are the targets of most chemotherapeutic agents. However, effective therapy against cell invasion has been less successful. Future treatment protocols must incorporate pharmacotherapeutic strategies that target resistant infiltrative glioma cells as well as proliferating ones. Thus, delineating the point of convergence of signaling pathways, which mediate glioma invasion, proliferation and apoptosis, may identify novel targets that can serve as possible points of therapeutic intervention. The optimization of novel strategies will require reliable preclinical testing using an in vivo animal model of brain invasion. Current applications of existing animal models are not currently optimized or characterized for use in glioma invasion research. As such, the development of a bona fide brain invasion model in vivo must be established. Progress in understanding molecular mechanisms driving glioma invasion will be critical to the success of managing and improving the outcome of patients with this grave disease.

AB - The efficacy of treating malignant gliomas with adjuvant therapies remains largely unsuccessful due to the inability to effectively target invading cells. Although our understanding of glioma oncogenesis has steadily improved, the molecular mechanisms that mediate glioma invasion are still poorly understood. It is clear that genetic alterations in malignant gliomas affect cell proliferation and cell cycle control, which are the targets of most chemotherapeutic agents. However, effective therapy against cell invasion has been less successful. Future treatment protocols must incorporate pharmacotherapeutic strategies that target resistant infiltrative glioma cells as well as proliferating ones. Thus, delineating the point of convergence of signaling pathways, which mediate glioma invasion, proliferation and apoptosis, may identify novel targets that can serve as possible points of therapeutic intervention. The optimization of novel strategies will require reliable preclinical testing using an in vivo animal model of brain invasion. Current applications of existing animal models are not currently optimized or characterized for use in glioma invasion research. As such, the development of a bona fide brain invasion model in vivo must be established. Progress in understanding molecular mechanisms driving glioma invasion will be critical to the success of managing and improving the outcome of patients with this grave disease.

KW - Animal model

KW - FAK

KW - Fn14

KW - Glioma

KW - Invasion

KW - Migration

KW - NF-κB

KW - Pyk2

KW - Rac1

KW - RhoA

UR - http://www.scopus.com/inward/record.url?scp=33746822722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746822722&partnerID=8YFLogxK

U2 - 10.1586/14737159.6.4.613

DO - 10.1586/14737159.6.4.613

M3 - Review article

VL - 6

SP - 613

EP - 626

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 4

ER -